Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aleafia Health Inc ALEAF

Aleafia Health Inc. is a Canada-based cannabis company. The Company offers cannabis products in Canada and destined for international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. It owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.


GREY:ALEAF - Post by User

Post by ST0PTHEMADNESSon Feb 19, 2022 4:19pm
361 Views
Post# 34445317

Aleafia is transforming business...

Aleafia is transforming business...towards a branded cannabis provider, with branded revenue representing 80% of total net revenue in 2021 compared to 33% in 2020

96% increase in branded cannabis net revenue to $28.7 million in 2021 from $14.6 million in 2020

396% increase in adult-use net revenue to $16.0 million in 2021 from $3.2 million in 2020

60% increase in branded cannabis net revenue to $8.3 million in Q4 2021 from $5.2 million in Q4 2020
 
33% increase in medical cannabis net revenue to $10.6 million in 2021 from $8.0 million in 2020
 
Consolidating medical market share with 17% growth in scripts in 2021 relative to 23% overall market decline

Average THC potency of 22% with up to 27% levels achieved in record-breaking outdoor harvest

Projecting Adjusted EBITDA Profitability during the Second Half of 2022
 

 
 

 
Aleafia is transforming business towards a branded cannabis provider, with branded revenue representing 80% of total net revenue in 2021 compared to 33% in 2020

96% increase in branded cannabis net revenue to $28.7 million in 2021 from $14.6 million in 2020

396% increase in adult-use net revenue to $16.0 million in 2021 from $3.2 million in 2020

60% increase in branded cannabis net revenue to $8.3 million in Q4 2021 from $5.2 million in Q4 2020
 
33% increase in medical cannabis net revenue to $10.6 million in 2021 from $8.0 million in 2020
 
Consolidating medical market share with 17% growth in scripts in 2021 relative to 23% overall market decline

Average THC potency of 22% with up to 27% levels achieved in record-breaking outdoor harvest

Projecting Adjusted EBITDA Profitability during the Second Hal

<< Previous
Bullboard Posts
Next >>